Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00367809 · ClinicalTrials.gov registry record · Phase 3

Wellness Interventions After Transplant Study

A Phase 3 study of Organ Transplant, sponsored by National Institute of Nursing Research (NINR).

Completed
Registry status
Phase 3
Development phase
140
Enrollment target
1
Study location

NCT00367809: Completed Phase 3 study of Organ Transplant, sponsored by National Institute of Nursing Research (NINR).

NCT00367809 is a Phase 3 study of Organ Transplant that has completed, run by National Institute of Nursing Research (NINR). The registered enrollment target is 140 participants, above the 111-participant average among 3 other Organ Transplant trials with a reported enrollment target (26% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00367809, a Phase 3 study of Organ Transplant, has completed, sponsored by National Institute of Nursing Research (NINR).

COMPLETED
Registry status
Phase 3
Development phase
140 participants
Enrollment target
1
Study location

Study Summary

The Wellness Interventions after Transplant (WIAT) Trial has reached its enrollment target. This trial is no longer recruiting new patients. Those currently enrolled will be followed for a year to evaluate trial outcomes. The purpose of this trial is to determine if training in Mindfulness-Based Stress Reduction can reduce symptom distress and improve quality of life in solid organ transplant recipients. Primary study outcomes are depression, anxiety and insomnia symptoms, measured by well-validated self-report scales. The impact of this program on objectively measured sleep outcomes, use of health care resources and costs will also be evaluated.

Conditions Studied

Interventions

  • BEHAVIORAL Health Education (HE)
  • BEHAVIORAL Delayed Intervention
  • BEHAVIORAL Mindfulness-Based Stress Reduction (MSBR)

Study Locations (1)

Minnesota

  • University of Minnesota Academic Health Center - Minneapolis

Trial Details

FieldValue
Enrollment Target 140 participants
Start Date 2003-08
Est. Completion 2008-05
Phase Phase 3

What the finished NCT00367809 record still lists

NCT00367809 is an interventional study that assigns participants to a tested intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap, above the 111-participant average among 3 other Organ Transplant trials with a reported enrollment target (26% higher).

The record links to 1 condition, with Organ Transplant appearing as the primary indexed condition, and to 3 interventions - of which Health Education (HE) is the first listed.

NCT00367809 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT00367809 about?

NCT00367809 is a clinical study titled "Wellness Interventions After Transplant Study". The Wellness Interventions after Transplant (WIAT) Trial has reached its enrollment target. This trial is no longer recruiting new patients. Those currently enrolled will be followed for a year to evaluate trial outcomes. The purpose of this trial is to determine if training in Mindfulness-Based St...

What is the current status of trial NCT00367809?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 140 participants. The study started on 2003-08. Estimated completion is 2008-05.

What conditions does trial NCT00367809 study?

This clinical trial studies the following conditions: Organ Transplant.

What interventions are being tested in trial NCT00367809?

The interventions under investigation include: Health Education (HE) (BEHAVIORAL), Delayed Intervention (BEHAVIORAL), Mindfulness-Based Stress Reduction (MSBR) (BEHAVIORAL).

Who is sponsoring clinical trial NCT00367809?

This trial is sponsored by National Institute of Nursing Research (NINR), which has 46 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00367809 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Organ Transplant

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01419561 · 140 participants · Phase 2

    Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)

  • NCT01624805 · 140 participants · Phase 2

    Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome

  • NCT02369770 · 140 participants · NA

    Sensory-Motor Rehabilitation Post Stroke

  • NCT02455193 · 140 participants · NA

    Neuronal Effects of Exercise in Schizophrenia

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00367809, the US trial registry maintained by the National Library of Medicine. NCT00367809 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.